Can one spinal injection cut opioid use after chest surgery?
NCT ID NCT07790250
First seen Aug 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time
Summary
This trial tests whether adding a single dose of morphine into the spinal fluid, given before surgery, can reduce opioid use and improve recovery in adults undergoing open chest surgery (thoracotomy). All participants receive a standard intercostal nerve block and usual pain medication. Half also get the spinal morphine injection. Researchers measure total opioid use in the first 24 hours after surgery, pain levels, quality of recovery, and lung function.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Intrathecal morphine
- What this could lead to
- If it works, this could lead to a simple, single-shot way to reduce opioid use and improve recovery after open chest surgery.
- What could go wrong
- This is a small, early-stage trial, and the added benefit of intrathecal morphine over standard care is not yet proven. There are also risks such as respiratory depression or itching.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Apr 2019
- Finished
-
Jan 2021
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 18 years or older. * Patients scheduled for elective open thoracotomy under general anesthesia. * Patients undergoing thoracotomy through a standard posterolateral or anterolateral thoracotomy incision. * Patients eligible to receive surgeon-performed intercostal nerve blockade as part of the standard postoperative analgesic protocol. * American Society of Anesthesiologists (ASA) physical status I-III. * Ability to understand the study procedures and comply with the study assessments. * Provision of written informed consent before enrollment. Exclusion Criteria: * Age \<18 years. * Emergency or urgent thoracic surgery. * Video-assisted thoracoscopic surgery (VATS), robotic-assisted thoracic surgery, or other minimally invasive procedures without an open thoracotomy. * Previous thoracic surgery on the operative side that may significantly alter thoracic wall innervation. * Contraindication to neuraxial anesthesia or intrathecal morphine, including: * Coagulopathy or clinically significant bleeding disorder. * Therapeutic anticoagulation precluding neuraxial procedures. * Local infection at the intended puncture site or systemic infection. * Known hypersensitivity to morphine or other study medications. * Severe spinal anatomical abnormalities preventing safe intrathecal access. * Increased intracranial pressure or other contraindications to spinal anesthesia. * Chronic opioid use or long-term opioid therapy before surgery. * Pre-existing chronic pain requiring regular analgesic medication. * Severe pre-existing pulmonary disease that would substantially interfere with postoperative pulmonary function assessment. * Pre-existing neurological or neuromuscular disease that could affect respiratory function, pain assessment, or mobilization. * Severe hepatic or renal dysfunction that could significantly affect opioid metabolism or elimination. * Pregnancy or breastfeeding. * Inability to communicate adequately or reliably report pain or complete the Quality of Recovery-15 (QoR-15) questionnaire. * Inability to perform reliable preoperative or postoperative pulmonary function testing. * Any condition judged by the investigator to make participation unsafe or to interfere substantially with study outcomes. * Refusal to participate or withdrawal of informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Intrathecal morphine are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bursa City Hospital
Bursa, nilüfer, 16010, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A Non-Opioid painkiller may cut opioid use after knee surgery
- Can a single spinal injection transform Post-Surgery pain relief?
- Which painkiller wins after hysterectomy? a Head-to-Head test
- Can a safer nerve block match the gold standard for Post-Mastectomy pain?
- Why do some patients still suffer pain after minimally invasive chest surgery?
- New Non-Addictive pain drug could curb opioid dependence after surgery